---
title: "Descartes-08 in Generalized myasthenia gravis: Administration"
description: "Formulary evidence on Descartes-08 in Generalized myasthenia gravis: Administration. Topics: Leukapheresis, then six once-weekly outpatient infusions without preconditioning chemotherapy; Personalized manufacture from the patient’s own collected cells; Infusion duration, premedication, and post-infusion observation: phase 2b. 3 evidence topics quoted from 3 sources."
canonical: "https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/product-information-and-disease-description/administration"
published: "2026-11-19T12:09:07-05:00"
modified: "2026-11-19T12:09:07-05:00"
---

# Descartes-08 in Generalized myasthenia gravis: Administration

<a id="heading-2.1.2.10.2"></a>

## 2.1.2.10.2 Administration

<a id="topic-2.1.2.10.2-1"></a>

### Leukapheresis, then six once-weekly outpatient infusions without preconditioning chemotherapy

> “Patients underwent a single leukapheresis to collect cells used to prepare Descartes-08 (Fig. 2a) and then received six once-weekly infusions of Descartes-08 or placebo in an outpatient setting without preconditioning chemotherapy.”

Source: [Fedak et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13004674/)

<a id="topic-2.1.2.10.2-2"></a>

### Personalized manufacture from the patient’s own collected cells

> “We aim to provide a personalized approach to treating patients that begins with the collection of a patient’s cells which we then use to manufacture our cell therapy product candidates.”
> “Once a patient’s cells have expanded in our process, we introduce mRNA to deliver a CAR into the cell.”

Source: [Cartesian Therapeutics Form 10-K (2026)](https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm)

<a id="topic-2.1.2.10.2-3"></a>

### Infusion duration, premedication, and post-infusion observation: phase 2b

> “Participants were then randomly assigned in a 1:1 ratio to receive intravenous treatment with Descartes-08 or placebo, administered once weekly for 6 weeks as an intravenous infusion over 20 min.”
> “Diphenhydramine (or an equivalent) and acetaminophen were administered 30 min before each infusion as premedications.”
> “Participants were observed for 1 h after each infusion.”

Source: [Vu et al. (2026a)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13004676/)

## Related pages
- [Descartes-08: Generalized myasthenia gravis](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis.md)
- [Descartes-08 in Generalized myasthenia gravis: Terms and abbreviations](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/terms-and-abbreviations.md)
- [Descartes-08: Generalized myasthenia gravis](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/executive-summary) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/executive-summary.md)
- [Descartes-08 in Generalized myasthenia gravis: Product information and disease description](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/product-information-and-disease-description.md)
- [Descartes-08 in Generalized myasthenia gravis: Clinical evidence](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/clinical-evidence.md)
- [Descartes-08 in Generalized myasthenia gravis: Economic information and modeling report](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/economics) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/economics.md)
- [Descartes-08 in Generalized myasthenia gravis: References](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/references) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/references.md)
